Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11676
NanoViricides
NNVC
$35.7M
| $90.3K | ﹤0.01% |
79,915
+63,154
| +377% | +$88.7K |
|
11677
CALL
Greystone Housing Impact Investors LP
GHI
$136M
| $90.3K | ﹤0.01% |
+13,100
| New | +$102K |
|
11678
CALL
BGC Group
BGC
$4.97B
| $90.2K | ﹤0.01% |
10,100
-17,400
| -63% | -$157K |
|
|
CRWU
11679
PUT
T-REX 2X Long CRWV Daily Target ETF
CRWU
$37M
| $90K | ﹤0.01% |
17,900
+4,900
| +38% | +$67.3K |
|
|
SLN
11680
PUT
Silence Therapeutics
SLN
$554M
| $90K | ﹤0.01% |
+14,800
| New | +$94.8K |
|
|
GIBO
11681
GIBO Holdings
GIBO
$79.2M
| $89.9K | ﹤0.01% |
+1,730
| New | +$102K |
|
|
ACH
11682
CALL
Accendra Health
ACH
$224M
| $89.3K | ﹤0.01% |
31,900
| – | – |
|
11683
PUT
Zevia
ZVIA
$106M
| $89.3K | ﹤0.01% |
38,500
+3,600
| +10% | +$8.94K |
|
|
ROLR
11684
High Roller Technologies
ROLR
$68.9M
| $89.3K | ﹤0.01% |
43,328
+28,856
| +199% | +$67K |
|
11685
flyExclusive
FLYX
$63.7M
| $89.1K | ﹤0.01% |
21,672
+7,860
| +57% | +$28.9K |
|
11686
PUT
NET Power
NPWR
$133M
| $88.7K | ﹤0.01% |
38,900
-23,600
| -38% | -$73.8K |
|
11687
Enel Chile
ENIC
$6.32B
| $88.6K | ﹤0.01% |
22,038
-159,006
| -88% | -$613K |
|
11688
CALL
Vista Gold
VGZ
$296M
| $88.5K | ﹤0.01% |
+44,900
| New | +$86.6K |
|
11689
Cineverse
CNVS
$62.3M
| $88.3K | ﹤0.01% |
41,866
-14,667
| -26% | -$39.7K |
|
|
AMBR
11690
Amber International Holding Ltd
AMBR
$128M
| $88.2K | ﹤0.01% |
50,995
-12,651
| -20% | -$25K |
|
11691
CALL
Jasper Therapeutics
JSPR
$21.5M
| $88.2K | ﹤0.01% |
48,200
+3,700
| +8% | +$7.43K |
|
11692
CALL
Puma Biotechnology
PBYI
$413M
| $88.1K | ﹤0.01% |
14,800
-8,500
| -36% | -$45.1K |
|
11693
PUT
Ring Energy
REI
$325M
| $87.9K | ﹤0.01% |
101,000
-2,600
| -3% | -$2.48K |
|
|
YRD
11694
PUT
Yiren Digital
YRD
$108M
| $87.7K | ﹤0.01% |
23,700
-3,900
| -14% | -$19.9K |
|
11695
Marker Therapeutics
MRKR
$18.7M
| $87.7K | ﹤0.01% |
+58,847
| New | +$66.6K |
|
11696
Cumberland Pharmaceuticals
CPIX
$115M
| $87.4K | ﹤0.01% |
21,957
-19,488
| -47% | -$57.8K |
|
|
RITR
11697
Reitar Logtech Holdings
RITR
$12M
| $87.2K | ﹤0.01% |
75,851
+56,028
| +283% | +$85.8K |
|
11698
PUT
Hyliion Holdings
HYLN
$704M
| $87.2K | ﹤0.01% |
47,400
-30,800
| -39% | -$62K |
|
11699
Talphera
TLPH
$74.2M
| $87.1K | ﹤0.01% |
+76,445
| New | +$92.2K |
|
11700
ChargePoint
CHPT
$152M
| $86.9K | ﹤0.01% |
13,094
-142,124
| -92% | -$1.34M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.